PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
All content for PeerVoice Immunology & Infectious Disease Audio is the property of PeerVoice and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
Thomas Dörner, MD - B-Cell Depletion for Autoimmune Rheumatic Diseases: Expert Perspectives of This Mechanistic Therapeutic Approach in Clinical Context
PeerVoice Immunology & Infectious Disease Audio
53 minutes 52 seconds
5 months ago
Thomas Dörner, MD - B-Cell Depletion for Autoimmune Rheumatic Diseases: Expert Perspectives of This Mechanistic Therapeutic Approach in Clinical Context
Visit https://www.peervoice.com/SDS860 to view the entire programme with slides. After completing “Thomas Dörner, MD - B-Cell Depletion for Autoimmune Rheumatic Diseases: Expert Perspectives of This Mechanistic Therapeutic Approach in Clinical Context”, participants will be able to: Explain the impact of suboptimal treatment of autoimmune rheumatic diseases on patient outcomes; Discuss the mechanistic role of B cells in the pathophysiology of autoimmune rheumatic diseases; Explain why—despite suboptimal results with established B-cell–targeting therapies in autoimmune rheumatic diseases such as Sjögren’s disease, systemic lupus erythematosus (SLE), and lupus nephritis—B-cell–targeting still holds therapeutic promise; and Identify B-cell–targeting therapies currently being investigated for autoimmune rheumatic diseases and their methods for achieving B-cell depletion.
PeerVoice Immunology & Infectious Disease Audio
PeerVoice is an independent, professional medical publishing concern focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerVoice Publications, PeerVoice is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.
